Drug Type CAR-NK |
Synonyms- |
Target |
Action modulators |
Mechanism CEA modulators(Carcinoembryonic antigen modulators), HER2 modulators(Receptor tyrosine-protein kinase erbB-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | - | 13 May 2025 |





